NAVIDEA BIOPHARMACEUTICALS I (NAVB) Earnings History & Surprises
NYSEARCA:NAVB • US63937X2027
0.0779 USD
0 (-2.99%)
Last: Oct 5, 2023, 08:04 PM
Past quarterly earnings results for NAVIDEA BIOPHARMACEUTICALS I (NAVB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateNov 13, 2023
Last Reported
Release DateAug 11, 2023
PeriodQ2 / 2023
EPS Reported
EPS Surprise %
Revenue Surprise %
Beat Rate
0%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | - | - | - | -100.00% | ||||
| Q1 2023 | - | - | - | - | ||||
| Q4 2022 | -0.11 | - | 8.33% | 610 | - | -98.79% | ||
| Q3 2022 | -0.25 | - | -212.50% | 7.52K | - | -92.20% | ||
| Q2 2022 | -0.10 | - | -11.11% | 57.53K | - | -77.96% | ||
| Q1 2022 | -0.10 | - | 9.09% | - | -100.00% | |||
| Q4 2021 | -0.12 | - | -9.09% | 50.35K | - | -77.04% | ||
| Q3 2021 | -0.08 | -0.11 | 28.70% | 38.46% | 96.38K | - | -64.09% | |
| Q2 2021 | -0.09 | -0.08 | -10.29% | 18.18% | 261.05K | 612K | -57.34% | -3.71% |
| Q1 2021 | -0.11 | -0.08 | -34.80% | 15.38% | 123.74K | 612K | -79.78% | -20.82% |
| Q4 2020 | -0.11 | -0.12 | 10.13% | - | 219.25K | 612K | -64.17% | - |
| Q3 2020 | -0.13 | -0.09 | -41.61% | - | 268.39K | 153K | 75.42% | - |
| Q2 2020 | -0.11 | -0.12 | 10.13% | - | 271.1K | 306K | -11.41% | - |
| Q1 2020 | -0.13 | - | - | 156.27K | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
NAVIDEA BIOPHARMACEUTICALS I / NAVB Earnings FAQ
What is the most recent earnings date for NAVB stock?
NAVIDEA BIOPHARMACEUTICALS I (NAVB) last reported earnings on 8/11/2023.
Did NAVIDEA BIOPHARMACEUTICALS I (NAVB) beat earnings estimates last quarter?
NAVIDEA BIOPHARMACEUTICALS I (NAVB) missed EPS estimates and missed revenue estimates in the most recent quarter.